Overall Response to First-Line Tyrosine Kinase Inhibitor and Second-Line Chemotherapy Is Predictive of Survival Outcome in Epidermal Growth Factor Receptor-Mutated Adenocarcinoma

Publisher: Karger

E-ISSN: 1421-9794|60|3|201-210

ISSN: 0009-3157

Source: Chemotherapy, Vol.60, Iss.3, 2015-04, pp. : 201-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content